Gilead sciences stock price.

To opt-in for investor email alerts, please: Enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. 77.89. 76.40. 4,877,200. *Close price adjusted for splits. **Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data... Discover historical prices for GILD stock on Yahoo Finance. View daily, weekly or monthly formats back to when Gilead Sciences, Inc. stock was issued.6. Gilead pays an attractive dividend yield. A profitable company that generates billions in cash flow is the type of business you would expect to pay a dividend. At 3.6%, Gilead's yield is more ...GILD Stock Summary. GILD has a higher market value than 97.69% of US stocks; more precisely, its current market capitalization is $94,599,500,668. GILD's went public 31.83 years ago, making it older than 83.17% of listed US stocks we're tracking.Dan O'Day is the chairman and CEO of Gilead Sciences Inc. ... The company's stock closed down 3.7% Monday, or $2.98 per share, to $77.66. ... The merger deal with Forty Seven — valuing the ...

Gilead Sciences (GILD) closed at $81.07 in the latest trading session, marking a +1.82% move from the prior day. This change outpaced the S&P 500's 1.62% gain on the day.Key Insights. Given the large stake in the stock by institutions, Gilead Sciences' stock price might be vulnerable to their trading decisions. 50% of the business is held by the top 17 shareholders

Gilead Sciences Stock: Bear vs. Bull. 488%. Motley Fool Returns. Market-beating stocks from our award-winning analyst team. Stock Advisor Returns. ... Stock Advisor list price is $199 per year.

Nov 15, 2023 · In addition to maintaining a strong R&D pipeline (which is its bread and butter), the company aims to maintain consistent dividend growth. The company currently pays a $0.75 per share per quarter ... Nov 27, 2023 · Get Gilead Sciences Inc (GILD.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments On September 30, 2021, Gilead Sciences had $2,511 million in short-term debt and $25,175 million in long-term debt. When comparing the total debt to the stockholders' equity of $21,471 million we ...Find out all the key statistics for Gilead Sciences, Inc. (GILD), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. ... Stock Price History ...UBS Adjusts Price Target on Gilead Sciences to $81 From $85, Maintains Neutral Rating Nov. 13: MT Wall Street: a surge in interest rates breaks the bullish rally ... Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. ... Stock Gilead Sciences, Inc. - Nasdaq . News Gilead …

Nov 24, 2023 · According to 14 stock analysts, the average 12-month stock price forecast for GILD stock stock is $89.36, which predicts an increase of 18.55%. The lowest target is $71 and the highest is $112. On average, analysts rate GILD stock stock as a buy.

Analyst's Opinion · Consensus Rating. Gilead Sciences has received a consensus rating of Hold. · Price Target Upside/Downside. According to analysts' consensus ...

Find the latest Gilead Sciences, Inc. (GILD) stock quote, history, news and other vital information to help you with your stock trading and investing.For the past 6 years, Gilead Sciences ( NASDAQ: GILD) has been trading in a tight range between $60 and $80. Each time the stock breaches either level, the price is not sustained by any measure ...In 2022, Gilead Sciences stock outperformed the S&P 500 In recent years you would have been better off investing in the S&P 500 most of the time because the index has fairly consistently ...GILD Overview Stock Screener Earnings Calendar Sectors Nasdaq | GILD U.S.: Nasdaq Gilead Sciences Inc. Watch NEW Set a price target alert After Hours Last Updated: Dec 1, 2023 7:59 p.m....Some might argue that Gilead Sciences (GILD-0.55%) is back. The stock trounced the S&P 500 in 2022. Despite a slower start this year, Gilead appears to be in pretty good shape to resume its momentum.Shares of Gilead Sciences ( GILD 1.30%) are jumping today, up by 6.5% as of 11:23 a.m. ET. The gain came after the big biotech announced its second-quarter results following the market close on ...

6. Gilead pays an attractive dividend yield. A profitable company that generates billions in cash flow is the type of business you would expect to pay a dividend. At 3.6%, Gilead's yield is more ...Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. Net sales break down by source of income as follows: - sale of drugs (98.9%): for the treatment of HIV (63% of net sales), COVID-19 (20.4%), hepatitis C virus (6.6%), hepatitis B virus (3.6%) and other (6.4%; primarily cytomegalovirus ...Gilead Sciences Inc. 333 Lakeside Drive. Foster City, California 94404. Phone 1 650 574-3000. Industry Biotechnology. Sector Health Care/Life Sciences. Fiscal Year-end 12/2023.In depth view into GILD (Gilead Sciences) stock including the latest price, news, dividend history, earnings information and financials.Its quarterly revenue was up .1% on a year-over-year basis. Gilead Sciences has generated $4.66 earnings per share over the last year ($4.66 diluted earnings per share) and currently has a price-to-earnings ratio of 16.7. Earnings for Gilead Sciences are expected to grow by 10.22% in the coming year, from $6.75 to $7.44 per share.Gilead Sciences, Inc. (/ ... citing a market capitalization of US$113 billion and stock appreciation of 100%, ... and argued in its 2015 report that Gilead set prices high in disregard of the human cost and in order to set the stage for a higher eventual price for Sovaldi's successor, Harvoni.

SOUTH SAN FRANCISCO, Dec. 4, 2023 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA), a precision medicine oncology company committed to …With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.

Buying Gilead means buying a company that has lost investor interest since 2015, and this can also be seen from the fact that in 2015 the Price per share was around $117, almost double the current ...Exact Sciences (EXAS) stock is on the rise Friday following news that Guardant Health's (GH) clinical trial didn't go as well as expected. GH is pushing EXAS higher today Source: Shutterstock Exact Sciences (NASDAQ:EXAS) stock is on the ris...Gilead Sciences, Inc. Common Stock (GILD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Gilead Sciences (GILD) came out with quarterly earnings of $1.90 per share, beating the Zacks Consensus Estimate of $1.44 per share. ... The 52-week range of Verizon's stock price was $30.135 to ...Sep-07-23 08:55PM. Gilead Prices $2 Billion of Senior Unsecured Notes. (Business Wire) 06:00PM. Gilead Sciences (GILD) Dips More Than Broader Markets: What You Should Know. (Zacks) Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements. Gilead is expected to post earnings of $1.43 ...Mar 12, 2023 · Given the large stake in the stock by institutions, Gilead Sciences' stock price might be vulnerable to their trading decisions. 51% of the business is held by the top 18 shareholders. New Zealand Stocks Edge Lower. Gilead Sciences traded at $78.54 this Tuesday October 31st, increasing $0.77 or 0.99 percent since the previous trading session. Looking back, over the last four weeks, Gilead Sciences gained 5.99 percent. Over the last 12 months, its price fell by 1.01 percent. Looking ahead, we forecast Gilead Sciences to be ...Guardant Health, Inc. (NASDAQ:GH) is a healthcare stock, but it operates in the wrong segment. GH is proof Guardant Health, Inc. (NASDAQ:GH) is a healthcare stock, but it operates in the wrong segment. Unlike companies like Emergent BioSolu...

Find the latest Gilead Sciences, Inc. (GILD) stock quote, history, news and other vital information to help you with your stock trading and investing. ... NasdaqGS Real-time price. Currency in USD. Add to watchlist. 77.65 +1.05 (+1.37%) ... 2023--Gilead Sciences, Inc. (Nasdaq: GILD) today announced it will present new data at San Antonio Breast ...

Dec 1, 2023 · Based on short-term price targets offered by 19 analysts, the average price target for Gilead Sciences comes to $89.68. The forecasts range from a low of $71.00 to a high of $115.00.

Stock split history for Gilead Sciences since 1992. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values. Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet ... Consensus Price Target is the stock price ...Gilead Sciences Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Pharma stock Gilead Sciences is well-positioned for the next few years with a growing core business, a healthy pipeline, and cash flow to sustain capital return . GILD: 77.65 (+1.37%)The average price target of $90.50 for Gilead Sciences Inc's stock set by fiveteen distinguished analysts in recent weeks would represent a potential upside of approximately 16.55% from the last closing price in December, 2023 if reached by the end of the year.Find the latest historical data for Gilead Sciences, Inc. Common Stock (GILD) at Nasdaq.com. We estimate Gilead Sciences’ valuation to be $62, aligning with its current market price. Although GILD stock is trading at a lower P/S multiple compared to the levels seen in 2017, it is ...In a report released today, Joseph Catanzaro from Piper Sandler maintained a Buy rating on Gilead Sciences (GILD – Research Report), with a price target of …Gilead Sciences' Earnings Per Share Are Growing. If a company can keep growing earnings per share (EPS) long enough, its share price should eventually follow. That makes EPS growth an attractive ...Interactive Chart for Gilead Sciences, Inc. (GILD), analyze all the data with a huge range of indicators. Home; Mail; ... NasdaqGS Real Time Price. Currency in USD. Follow. Visitors trend 2W 10W ... Why Gilead Sciences Stock Is Jumping Today. ... Shares of Gilead Sciences (GILD 1.37%) ... Harrison set a one-year price target for Gilead of $83, reflecting a premium of 31% above the closing ...Gilead Sciences reported 79% growth for its cancer drugs late Thursday, helping beat expectations. On Friday, GILD stock broke out.Company insiders own 0.16% of the company's stock. Gilead Sciences Price Performance. Buying the dip in high-yield Gilead Sciences Gilead Sciences stock traded up $0.25 during midday trading on Friday, reaching $76.85. The company's stock had a trading volume of 1,200,104 shares, compared to its average volume of 5,747,694.

Jul 24, 2023 · Gilead Sciences (GILD Quick Quote GILD - Free Report) ... This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it ... Get the latest Gilead Sciences, Inc. (GILD) stock news and headlines to help you in your trading and investing decisions. ... Fair Value is the appropriate price for the shares of a company, based ...Gilead Sciences is still deeply undervalued, which should lead to higher stock prices in the coming quarters. But maybe a catalyst is necessary to driver the stock price higher.Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. Net sales break down by source of income as follows: - sale of drugs (98.9%): for the treatment of HIV (63% of net sales), COVID-19 (20.4%), hepatitis C virus (6.6%), hepatitis B virus (3.6%) and other (6.4%; primarily cytomegalovirus ...Instagram:https://instagram. cheapest cash app stockspaypal to western unionbest budget sheeton communication book Historical daily share price chart and data for Gilead Sciences since 1992 adjusted for splits and dividends. The latest closing stock price for Gilead Sciences as of December 01, 2023 is 77.65.. The all-time high Gilead Sciences stock closing price was 91.98 on June 23, 2015.; The Gilead Sciences 52-week high stock price is 89.74, which is 15.6% … delaware llc privacyhow to buy peacock stock Exact Sciences (EXAS) stock is on the rise Friday following news that Guardant Health's (GH) clinical trial didn't go as well as expected. GH is pushing EXAS higher today Source: Shutterstock Exact Sciences (NASDAQ:EXAS) stock is on the ris... cambel soup Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Gilead Sciences, Inc. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: GILD | NasdaqIn 2022, Gilead Sciences stock outperformed the S&P 500 In recent years you would have been better off investing in the S&P 500 most of the time because the index has fairly consistently ...